Sep 16, 2020 / 12:45PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Well, good morning, everyone, and welcome to the Morgan Stanley Healthcare Conference 2020. As we enter day 3, we progress through the morning.
It's my pleasure to have with us here, as we start here in the morning on day 3, Becton, Dickinson, and 2 members of management, both Tom Polen, CEO; and Chris Reidy, CFO; and then Kristen is hanging out there somewhere with a smiley face on the strip there.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDSo we're going to dispense with my normal progression here. You guys have gotten used to these last 3 days talking about COVID upfront. I want to get with Tom's strategy here to start off our conversation. And Tom, I -- we've talked about this a little bit off-line, but I've covered the company almost 2 decades. It's dating myself a little bit there. I think investors have always appreciated the durability of Becton, Dickinson, the consistency of Becton, Dickinson. And I think in the last 6 to 8 quarters, they feel